| Literature DB >> 23758715 |
D Kevin Horton1, Olorunfemi Adetona, Manuel Aguilar-Villalobos, Brandon E Cassidy, Christine M Pfeiffer, Rosemary L Schleicher, Kathleen L Caldwell, Larry L Needham, Stephen L Rathbun, John E Vena, Luke P Naeher.
Abstract
BACKGROUND: In developing countries, deficiencies in essential micronutrients are common, particularly in pregnant women. Although, biochemical indicators of diet and nutrition are useful to assess nutritional status, few studies have examined such indicators throughout pregnancy in women in developing countries.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23758715 PMCID: PMC3685542 DOI: 10.1186/1475-2891-12-80
Source DB: PubMed Journal: Nutr J ISSN: 1475-2891 Impact factor: 3.271
Biochemical indicators of diet and nutrition listed by class, laboratory analysis method, and abbreviation
| HPLC-UV1 | |
| Vitamin A (retinol) | 3.5-3.8% at 0.70-3.50 μmol/L |
| Vitamin A (retinyl palmitate) | >30% at < 0.15 μmol/L |
| Vitamin A (retinyl stearate) | >30% at < 0.15 μmol/L |
| Vitamin E ( | 2.6-3.0% at 11.6-232 μmol/L |
| Vitamin E ( | 3.0-4.0% at 2.40-11.9 μmol/L |
| HPLC-UV | |
| | 6.0-13.0% at >0.28 μmol/L |
| | 6.0-13.0% at >0.28 μmol/L |
| | 6.0-13.0% at >0.28 μmol/L |
| | 6.0-13.0% at >0.27 μmol/L |
| Lutein + Zeaxanthin | 6.0-13.0% at >0.26 μmol/L |
| | 6.0-13.0% at >0.28 μmol/L |
| total Lycopene | 6.0-13.0% at >0.28 μmol/L |
| Immunoturbidimetry | |
| Ferritin | 6.1-7.4% at 79–426 μg/L |
| Colorimetry | |
| Iron | 1.7-1.9% at 13.1-30.0 μmol/L |
| Unbound Iron-Binding Capacity | 2.5-3.0% at 28.0-41.4 μmol/L |
| Total Iron-Binding Capacity | N/A (calculated value) |
| Transferrin Saturation | N/A (calculated value) |
| Atomic absorption spectrometry | |
| Selenium | 0.04% |
1HPLC-UV high performance liquid chromatography.
Personal and household characteristics of 78 pregnant Peruvian women
| 78 | --- | |
| ≤ 20 | 16 | 20.5% |
| 21–25 | 26 | 33.3% |
| 26–29 | 19 | 24.4% |
| ≥ 30 | 17 | 21.8% |
| 78 | --- | |
| Primary | 16 | 20.5% |
| Secondary | 45 | 57.7% |
| Superior | 17 | 21.8% |
| | 78 | --- |
| Lower | 50 | 64.1% |
| Middle/Upper | 28 | 35.9% |
| | 78 | --- |
| Gas | 47 | 60.3% |
| No gas | 31 | 39.7% |
| 78 | --- | |
| Central | 17 | 21.8% |
| North | 56 | 71.8% |
| South | 5 | 6.4% |
1Total number of subjects for which the response is known.
2Percentages are calculated from the known number of responses in column 2.
3Gas = gas, combination including gas, electricity; No gas = wood, kerosene, vegetable carbon, combination not including gas.
4Central = Trujillo; north = La Esperanza, El Porvenir, Florencia de Mora, and El Milagro; and south = Moche and Alto Trujillo.
Serum concentration distributions of select biochemical indicators for pregnant Peruvian women
| Retinol | 0.035 | 0.0 | 193 | 1.43 (1.40-1.49) | 1.46 | 0.74 | 2.63 | 0.0 | 52 | 0.64 (0.60-0.69) | 0.66 | 0.34 | 1.29 | ≤ 0.0001 |
| Retinyl palmitate | 0.025 | 65.3 | 193 | NC5 | LOD | LOD | 0.11 | 100.0 | 52 | NC | NC | LOD | LOD | NC |
| Retinyl stearate | 0.013 | 97.4 | 193 | NC | LOD | LOD | 0.027 | 100.0 | 52 | NC | NC | LOD | LOD | NC |
| Alpha-tocopherol | 0.94 | 0.0 | 193 | 27.2 (26.2-28.3) | 27.9 | 14.3 | 46.0 | 0.0 | 52 | 5.92 (5.52-6.35) | 5.80 | 3.60 | 15.5 | ≤ 0.0001 |
| Gamma-tocopherol | 0.26 | 0.0 | 193 | 3.14 (2.98-3.32) | 3.21 | 1.10 | 7.68 | 17.3 | 52 | 0.35 (0.31-0.39) | 0.34 | 0.18 | 0.98 | ≤ 0.0001 |
| Alpha-carotene | 0.013 | 0.0 | 193 | 0.19 (0.18-0.21) | 0.19 | 0.042 | 1.14 | 65.4 | 52 | NC | NC | LOD | 0.007 | NC |
| Beta-carotene | 0.015 | 0.0 | 193 | 0.21 (0.20-0.23) | 0.21 | 0.050 | 1.90 | 69.2 | 52 | NC | NC | LOD | 0.005 | NC |
| Cis-beta-carotene6 | 0.013 | 23.9 | 71 | 0.018 (0.017-0.020) | 0.017 | 0.009 | 0.12 | 100.0 | 31 | NC | NC | LOD | LOD | NC |
| Beta-cryptoxanthin | 0.016 | 0.0 | 193 | 0.43 (0.39-0.47) | 0.45 | 0.07 | 2.39 | 0.0 | 52 | 0.052 (0.045-0.063) | 0.051 | 0.018 | 0.26 | ≤ 0.0001 |
| Lutein + zeaxanthin | 0.042 | 0.0 | 193 | 0.53 (0.50-0.58) | 0.53 | 0.11 | 1.24 | 0.0 | 52 | 0.11 (0.10-0.12) | 0.10 | 0.065 | 0.28 | ≤ 0.0001 |
| Trans-lycopene | 0.015 | 0.5 | 193 | 0.058 (0.052-0.063) | 0.054 | 0.011 | 0.53 | 100.0 | 52 | NC | NC | LOD | LOD | NC |
| Total lycopene | 0.019 | 0.0 | 193 | 0.15 (0.14-0.18) | 0.15 | 0.028 | 1.04 | 94.2 | 52 | NC | NC | LOD | 0.050 | NC |
| Ferritin7 | 6.81 | 0.0 | 192 | 52.1 (45.2-60.2) | 52.8 | 6.74 | 528 | 0.0 | 47 | 321 (272–377) | 315 | 101 | 1090 | ≤ 0.0001 |
| Iron | 0.90 | 0.0 | 202 | 12.1 (11.2-13.0) | 12.8 | 2.33 | 30.6 | 0.0 | 47 | 26.2 (24.4-28.2) | 26.9 | 12.0 | 36.2 | ≤ 0.0001 |
| Unbound iron capacity | 1.80 | 0.0 | 182 | 55.6 (52.9-58.4) | 56.9 | 24.2 | 128 | 0.0 | 42 | 10.0 (8.09-12.6) | 10.4 | 1.79 | 31.7 | ≤ 0.0001 |
| Total iron bound capacity8 | N/A | 0.0 | 181 | 71.3 (69.0-71.3) | 70.0 | 34.7 | 134 | 0.0 | 42 | 38.2 (36.2-40.3) | 37.5 | 25.1 | 57.7 | ≤ 0.0001 |
| Transferrin saturation9 | N/A | 0.0 | 181 | 17.9 (16.4–19.6) | 19.0 | 3.0 | 53.0 | 0.0 | 42 | 67.0 (61.7–72.6) | 73.5 | 34.0 | 95.0 | ≤ 0.0001 |
| Selenium | 0.063 | 0.0 | 204 | 1.44 (1.41-1.44) | 1.46 | 0.79 | 2.15 | 0.0 | 44 | 0.86 (0.83-0.89) | 0.87 | 0.61 | 1.14 | ≤ 0.0001 |
1All values expressed in μmol/L unless otherwise noted.
2LOD limit of detection.
3GM geometric means; 95% CI = 95% confidence interval.
4p-values are based on a t-test and compare trimesters 1–3 combined with cord serum.
5NC not calculated. No calculations were conducted on samples for which 40% or more of the values were < LOD as per CDC methodology guidelines (17). For all other samples < LOD, calculations were based upon the LOD values divided by the square root of two.
6Because of laboratory quality control issues, the total sample size for CBC is lower compared with the remaining biochemical indicators.
7Values expressed in pmol/L (1 pmol/L = 2.247 ng/ml).
8TIBC total iron-binding capacity. TIBC = IRN + UIBC.
9Transferrin saturation = IRN/TIBC. Values expressed in %. TS does not have a specified LOD.
Unadjusted serum concentrations of select biochemical indicators for pregnant Peruvian women across trimesters
| Retinol | 66 | 1.40 (1.34-1.46)a | 65 | 1.54 (1.46-1.63)b | 62 | 1.39 (1.31-1.47)a | 0.001 |
| Alpha-tocopherol | 66 | 21.3 (20.3-22.5)a | 65 | 29.0 (27.5-30.6)b | 62 | 32.9 (31.4-34.5)c | ≤ 0.0001 |
| Gamma-tocopherol | 66 | 2.67 (2.44-2.92)a | 65 | 3.35 (3.06-3.68)b | 62 | 3.49 (3.17-3.83)b | ≤ 0.0001 |
| Alpha-carotene | 66 | 0.18 (0.16-0.20)a | 65 | 0.19 (0.17-0.21)a | 62 | 0.22 (0.19-0.25)b | 0.024 |
| Beta-carotene | 66 | 0.20 (0.18-0.23)a | 65 | 0.19 (0.17-0.23)a | 62 | 0.25 (0.21-0.30)b | 0.014 |
| Cis-beta-carotene | 0 | NC6 | 53 | 0.017 (0.013-0.019)a | 18 | 0.028 (0.020-0.037)b | 0.01 |
| Beta-cryptoxanthin | 66 | 0.41 (0.35-0.49)a | 65 | 0.40 (0.34-0.47)a | 62 | 0.46 (0.40-0.54)a | 0.31 |
| Lutein + zeaxanthin | 66 | 0.41 (0.37-0.45)a | 65 | 0.58 (0.52-0.63)b | 62 | 0.61 (0.57-0.67)b | ≤ 0.0001 |
| Trans-lycopene | 66 | 0.047 (0.041-0.054)a | 65 | 0.052 (0.045-0.061)a | 62 | 0.080 (0.065-0.095)b | ≤ 0.0001 |
| Total-lycopene | 66 | 0.14 (0.12-0.16)a | 65 | 0.13 (0.11-0.15)a | 62 | 0.20 (0.18-0.24)b | ≤ 0.0001 |
| Ferritin7 | 78 | 102 (100–141)a | 61 | 37.9 (31.3-45.8)b | 53 | 23.4 (19.5-27.9)c | ≤ 0.0001 |
| Iron | 78 | 16.1 (14.6-17.8)a | 64 | 11.8 (10.5-13.2)b | 60 | 8.47 (7.43-9.71)c | ≤ 0.0001 |
| Unbound iron binding capacity | 78 | 42.5 (40.1-45.1)a | 63 | 64.6 (61.2-68.3)b | 41 | 73.5 (67.9-79.5)c | ≤ 0.0001 |
| Total iron binding capacity8 | 78 | 60.8 (58.9-62.7)a | 63 | 78.2 (75.2-81.4)b | 40 | 83.9 (77.9-90.4)b | ≤ 0.0001 |
| Transferrin saturation9 | 78 | 26.6 (20.0–30.0)a | 63 | 15.2 (10.0–20.0)b | 40 | 10.8 (10.0–15.0)b | 0.0001 |
| Selenium7 | 78 | 1.51 (1.48-1.55)a | 64 | 1.42 (1.37-1.48)b | 62 | 1.37 (1.30-1.43)b | 0.0003 |
1Does not include cord serum.
2Retinyl palmitate and retinyl stearate were excluded because ≥ 40% of their respective values were < LOD.
3All values expressed in μmol/L unless otherwise noted.
4GM geometric means; 95% CI = 95% confidence interval.
5p-values were calculated using a Mixed Effects Model procedure.
6NC not calculated. Because of laboratory quality control issues, Trimester 1 samples were not analyzed. Therefore, the sample sizes across trimesters are lower for CBC compared with the remaining biochemical indicators.
7Values expressed in pmol/L (1 pmol/L = 2.247 ng/ml).
8TIBC total iron-binding capacity. TIBC = IRN + UIBC.
9Transferrin saturation = IRN/TIBC. Values expressed in %.
Note: the superscript letters “a”, “b” and “c” are used to distinguish whether trimesters have statistically significantly (p < 0.05) different biomarker concentrations. Trimesters with different letter superscript have significantly different concentrations while those with the same superscript letters do not.
Serum biochemical indicators of pregnant Peruvian women by significant covariates
| ≤ 20 | 0.060 | 0.045-0.082 | 0.02 |
| 21–25 | 0.054 | 0.041-0.071 | |
| 26–29 | 0.078 | 0.060-0.10 | |
| ≥ 30 | 0.058 | 0.047-0.075 | |
| | |||
| Primary | 0.16 | 0.12-0.20 | 0.03 |
| Secondary | 0.24 | 0.20-0.28 | |
| Superior | 0.26 | 0.20-0.34 | |
| | |||
| Primary | 0.33 | 0.26-0.42 | 0.02 |
| Secondary | 0.45 | 0.38-0.54 | |
| Superior | 0.56 | 0.43-0.73 | |
| | |||
| Primary | 0.045 | 0.036-0.058 | 0.03 |
| Secondary | 0.063 | 0.052-0.076 | |
| Superior | 0.071 | 0.052-0.093 | |
| | |||
| Lower | 0.49 | 0.43-0.57 | 0.05 |
| Middle/Upper | 0.59 | 0.51-0.69 | |
1Does not include cord serum.
2All values expressed in μmol/L unless otherwise noted.
3Only covariates that significantly impact biochemical indicators are presented.
4GM geometric means.
595% CI = 95% confidence intervals.
6p-values were calculated using a Mixed Effects Model procedure.
Concentrations of biochemical indicators in Peruvian women and in US women in the 2003–04 National Health and Nutrition Examination Survey (NHANES)
| | ||||
|---|---|---|---|---|
| Retinol | 1.43 (1.40-1.49) | 193 | 1.33 (1.28-1.38) | 248 |
| Alpha-tocopherol | 27.2 (26.2-28.3) | 193 | 29.4 (28.0-30.9) | 248 |
| Gamma-tocopherol | 3.14 (2.98-3.32) | 193 | 4.77 (4.51-5.04) | 248 |
| Alpha-carotene | 0.19 (0.18-0.21) | 193 | 0.048 (0.043-0.054) | 248 |
| Beta-carotene | 0.21 (0.20-0.23) | 193 | 0.23 (0.21-0.25) | 248 |
| Cis-beta-carotene | 0.018 (0.017-0.020) | 71 | 0.019 (0.019-0.020) | 248 |
| Beta-cryptoxanthin | 0.43 (0.39-0.47) | 193 | 0.19 (0.17-0.20) | 248 |
| Lutein + zeaxanthin | 0.53 (0.50-0.58) | 193 | 0.30 (0.28-0.31) | 248 |
| Trans-lycopene | 0.058 (0.052-0.063) | 193 | 0.41 (0.39-0.43) | 248 |
| Total lycopene | 0.15 (0.14-0.18) | 193 | 0.77 (0.72-0.81) | 248 |
| Iron | 12.1 (11.2-13.0) | 202 | 13.5 (12.7-14.3) | 251 |
| Ferritin (pmol/L)3 | 52.1 (45.2-60.2) | 192 | 52.1 (47.0-58.0) | 250 |
| Total iron bound capacity | 71.2 (69.0-71.3) | 181 | 77.1 (75.1-79.0) | 251 |
| Transferrin saturation (%) | 17.9 (16.4-19.6) | 181 | 17.5 (16.3-18.7) | 251 |
1All concentrations expressed as μmol/L except otherwise stated.
2The Peru concentrations are geometric means calculated from data for all pregnant women having measurements across all trimesters.
3For ferritin, (1 pmol/L = 2.247 ng/ml).
Micronutrient deficiencies among pregnant Peruvian women in comparison with pregnant women from 2003–04 NHANES
| Ferritin | ≤ 15 ng/mL4 (33.7 pmol/L) | 5 | 78 | 6.4 | 27 | 61 | 44.3 | 38 | 53 | 71.7 | 92 | 250 | 36.8 |
| Selenium | ≤ 70 ng/mL (0.90 μmol/L)5 | 0 | 78 | 0.0 | 0 | 64 | 0.0 | 1 | 62 | 1.6 | 0 | 2 | 0.0 |
| Transferrin saturation | ≤ 16%4 | 10 | 78 | 12.8 | 29 | 63 | 46.0 | 31 | 40 | 77.5 | 100 | 251 | 39.8 |
1Of the 16 maternal biochemical indicators analyzed for this study, only 5 have clinically deficient definitions established: retinol, α-tocopherol, ferritin, selenium, and transferrin saturation. Since none of the Peruvian women were clinically deficient in retinol and α-tocopherol, these values are omitted.
2Micronutrient deficiency definitions do not necessarily pertain to newborns; therefore, cord serum was not included.
3% = deficient women/total women × 100.
4(23).
5(24).